BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Kidney
,
Neocentromeres
,
Tamoxifen
,
rs2300478
,
GATA1
,
cell-cell adhesion
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dCMP deaminase
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti…
Deoxyuridine analog nucleotides in deoxycytidine analog treatment: secondary active metabolites?
Chloroviruses encode a bifunctional dCMP-dCTP deaminase that produces two key intermediates in dTTP …
An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.
Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemos…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cytochlor and Tetrahydrouridine as Radiosensitizers and Cisplatin Combined With Radiation Therapy in…
5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer
Imaging Study for FdCyd and THU Cancer Treatment
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ